tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR

Arrowhead Pharmaceuticals (ARWR) Revenue

Compare
1,653 Followers

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had a revenue of 27.77M in the quarter ending Jun 30, 2025, with -94.88%. This bring the company's revenue in the last twelve months to 596.57M, Decreased 4.88%. In the fiscal year ending Dec 31, 2025, Arrowhead Pharmaceuticals had annual revenue of 829.45M with 23258.15% growth.
Revenue (ttm)
596.57M
Revenue Growth
23258.15%
P/S Ratio
11.48
Revenue/Employee
$1,361,984
Employees
609
Market Cap
$9.52B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
829.45M825.90M+23,358.16%
Dec 31, 2024
3.55M-237.18M+1.48%
Dec 31, 2023
240.74M-2.50M+98.97%
Dec 31, 2022
243.23M104.94M+175.89%
Dec 31, 2021
138.29M50.30M+157.16%
Dec 31, 2020
87.99M-80.80M+52.13%
Dec 31, 2019
168.80M152.65M+1,045.67%
Dec 31, 2018
16.14M-15.27M+51.40%
Dec 31, 2017
31.41M31.25M+19,836.61%
Dec 31, 2016
158.33K